HCP stock: buy or sell?
November 8th, 2019
HCP, Inc. is a fully integrated real estate investment trust (REIT) that invests primarily in real estate serving the healthcare industry in the United States.
Should I buy HCP stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best time to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, HCP stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is HCP stock a buy?
Financial institutions and banks post stock ratings everyday.At Stocks2.com, we collected 8 ratings published for HCP stock in the last month. The general sentiment of these ratings is bullish for HCP stock, with 6 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-9-17||Morgan Stanley||n/a||Equal Weight|
|2019-9-10||JPMorgan Chase & Co.||n/a||Neutral|
|2019-6-13||Raymond James||Market Perform||Outperform|
HCP stock analysis
HCP remained stable a tight 0.15% and closed at $33.69.
HCP remained stable a tight 0.15% and closed at $33.69. On October, HCP hit new all time highs, pushing higher previous ATH of $37.56 recorded on October. New ATHs are usual entry points for many trading setups as there aren't higher resistences.
HCP shares collapsed -8.23% early November, ending at $33.69.
HCP stock is drawing an uptrend with rising tops and bottoms. Now trading in between its last bottom and last top, HCP might consolidate in a flat-base, waiting to break out over or down under . Not so far away is the last price record HCP marked late October 2019. Early November, HCP stock lost the significant level of the 20-weeks moving average.
HCP stock price history
HCP IPO was on May 23rd, 1985 at $0.00 per share1. Since then, HCP stock grew a inf%, with an average of inf% per year. If you had invested $1,000 in HCP stock in 1985, it would worth $inf today.
1: Adjusted price after possible price splits or reverse-splits.
HCP stock historical price chart
HCP stock reached all-time highs on October with a price of $37.56.
HCP stock price target is $35.30Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. We detected 7 price forecasts for HCP stock published in the last month:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-9-17||Morgan Stanley||Raises Target||$32.00||$35.00||9.4%|
|2019-9-10||JPMorgan Chase & Co.||Raises Target||$32.00||$35.00||9.4%|
|2019-8-1||Stifel Nicolaus||Raises Target||$32.00||$34.00||6.3%|
Financials and fundamental analysis
Earnings date and Earnings per ShareOn February, HCP presented its financial report, aligned with analysts' consensus and published a $0.43 Earnings per Share. As soon as we get its posted EPS from the earnings report, we will extend this review.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, HCP annual turnover stepped up a slightly good 2.54% to $1,782.01 M dollars from $1,737.92 marked in 2017. When comparing 2018 vs 2017, on the other hand, profit margin (that is, the net income divided by revenues) climbed a 35.71% to 59.54%.
|2013||$2,110 M||-||$895 M42.4%||-|
|2014||$1,529 M||-27.55%||$922 M60.3%||3.07%|
|2015||$1,798 M||17.63%||$-559.24 M-31.1%||-160.64%|
|2016||$1,981 M||10.16%||$628 M31.7%||-212.25%|
|2017||$1,738 M||-12.27%||$414 M23.8%||-34.02%|
|2018||$1,782 M||2.54%||$1,061 M59.5%||156.20%|
Quarterly financial resultsHCP reported $426.62 M in revenues for 2018-Q4, a -3.31% less compared to previous quarter. Reported quarter earnings marked $831.55 M with a profit margin of 194.92%. Profit margin boosted a 172.39% compared to previous quarter when profit margin was 22.52%. When comparing turnover to same quarter last year, HCP sales marked a tight movement and stayed constant a 0.55%. Looking back to recent quarterly results, HCP posted 3 negative quarters in a row.
|2017-Q2||$459 M||-||$19 M4.2%||-|
|2017-Q3||$429 M||-6.52%||$-8 M-1.8%||-139.71%|
|2017-Q4||$424 M||-1.10%||$-59 M-13.8%||666.64%|
|2018-Q1||$460 M||8.31%||$40 M8.8%||-168.54%|
|2018-Q2||$455 M||-1.08%||$90 M19.8%||123.56%|
|2018-Q3||$441 M||-2.95%||$99 M22.5%||10.48%|
|2018-Q4||$427 M||-3.31%||$832 M194.9%||736.81%|
|2019-Q1||$421 M||-1.34%||$61 M14.6%||-92.61%|
HCP ownershipWhen you are planning to invest in shares of a company, it's always worth to overview its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For HCP, of all outstanding shares are owned by its staff.
Bearish positions for HCP stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to HCP:
|Market cap||$16.5 B|
|Total shares||491.1 M|
|Float shares||493.7 M|
|- Institutional holdings (%)||0.0%|
|- Insider holdings (%)||0.0%|
|Shares in short selling||0.0%|
|Friday, November 8th, 2019|
|Day range||$33.38 - $33.83|
|Average true range||$0.95|
|50d mov avg||$35.49|
|100d mov avg||$33.98|
|200d mov avg||$32.00|
HCP performanceTo better understand HCP performance you must becnhmark its gains with other related stocks in same sector or industry. In the following table, we compare HCP to :